The Ohio Academy of Family Physicians recently joined the Ohio State Medical Association (OSMA) and a number of other physician organizations in submitting comments to the State of Ohio Board of Pharmacy’s (SOBP) draft compounding rules. The comment period for the draft rules ended February 1.
“While all physicians agree that compounding activities should be performed in the safest manner possible, it is important to note that the legislative and regulatory backlash against prescriber compounding began not as a result of physicians mishandling compounded medications, but rather as the result of the contamination of compounded products made by a compounding pharmacy. Throughout the several years of drafting and redrafting compounding rules in Ohio, the SOBP and the State Medical Board of Ohio have yet to provide data that shows Ohio physicians are not compounding properly in physician offices. Physicians are trained to respond and react to evidence-based findings and, as we have stated previously, physicians believe that in-office compounding activities in Ohio have been safely performed for decades and do not require such stringent regulations.”
- Diluting prescription drugs with sterile saline for injection based on physician’s clinical judgement and adjusted to meet the patient’s need
- Tumescent anesthesia
- Buffering lidocaine with epinephrine and sodium bicarbonate for in-office surgical procedures
- Diluting steroid with lidocaine or saline for cyst, joint or scar injection
- Lidocaine mixed with Rocephin to decrease the injection pain
- Diluting or creating allergens for injection or skin testing
- Mixing of Albuterol/Atrovent in one nebulizer treatment to form a duoneb.”
Thanks to Jennifer Hayhurst of the OSMA staff for coordinating the comment effort!
1 thought on “OAFP Submits Comments to Pharmacy Board on Compounding Rules Draft”
To go after physicians, when the problem is pharmacists is the height of inappropriate excercise of bureaucracy.